MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$99,961K
(-1.66%↓ Y/Y)
Interest income
$6,130K
(-18.87%↓ Y/Y)
Gain on long-term
investment
$3,390K
Loss from operations
before income taxes
-$99,961K
(-1.66%↓ Y/Y)
Total other income and
expense
$9,296K
(25.06%↑ Y/Y)
(amortization of premium)
accretion of discount on...
-$111K
Interest expense
$95K
(-30.66%↓ Y/Y)
Other expense, net
-$18K
(-100.00%↓ Y/Y)
Operating loss
-$109,257K
(-3.30%↓ Y/Y)
Total operating
expenses
$109,257K
(3.30%↑ Y/Y)
Research and development
expenses
$63,797K
(-13.89%↓ Y/Y)
General and
administrative
$45,460K
(43.52%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Lexeo Therapeutics, Inc. (LXEO)
Lexeo Therapeutics, Inc. (LXEO)